You are viewing an incomplete version of our website. Please click to reload the website as full version.

Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (Internal Region) Peptide

Details for Product No. ABIN1382352, Supplier: Log in to see
Protein Name
  • AI838259
  • Bid3
  • DP5
  • Dp5
  • HARAKIRI
  • harakiri
Protein Region
Internal Region
Origin
Human
2
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-HRK antibody (Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain)) (Middle Region) (ABIN1030949)
Characteristics 15 amino acids near the center of human Hrk.
Human
Research Area Apoptosis/Necrosis
Application Notes Hrk peptide is used for blocking the activity of Hrk.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Hisada, Kamiya, Fujita, Belladonna, Aoki, Koyanagi, Mizuguchi, Yoshimoto: "Potent antitumor activity of interleukin-27." in: Cancer research, Vol. 64, Issue 3, pp. 1152-6, 2004 (PubMed).

Imaizumi, Tsuda, Imai, Wanaka, Takagi, Tohyama: "Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death." in: The Journal of biological chemistry, Vol. 272, Issue 30, pp. 18842-8, 1997 (PubMed).